{
  "id": "cluster_38_doc4",
  "content": "Research brief: Patients completing full 3-year allergy immunotherapy course in Central Texas demonstrated 60% reduction in related medication usage. Study period covered 2020-2023 across 8 clinics. Demographic breakdown showed highest adherence rates in 30-39 age group.",
  "metadata": {
    "format": "research_note"
  }
}